Regional differences in the response of human pre-adipocytes to PPARγ and RXRα agonists

被引:82
作者
Sewter, CP
Blows, F
Vidal-Puig, A
O'Rahilly, S
机构
[1] Addenbrookes Hosp, Dept Med, Cambridge CB2 2QR, England
[2] Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England
关键词
D O I
10.2337/diabetes.51.3.718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously reported that omental (OM) pre-adipocytes respond less well to the prodifferentiating effects of thiazolidinediones than do preadipocytes from subcutaneous (SC) depots. This finding is consistent with in vivo alterations in fat distribution that occur in humans treated with thiazolidinediones. To explore these site-related differences further, we used real-time RT-PCR to quantify the specific mRNAs encoding peroxisome proliferator-activated receptor (PPAR) gamma1 and gamma2 and found that both isoforms were more highly expressed in SC than in OM preadipocytes. After 10 days of thiazolidinedione treatment, preadipocytes from both depots showed a small and comparable increase in expression of PPARgamma1 mRNA (1.7 +/- 0.2-fold [P = 0.007]) and 1.3 +/- 0.1-fold [P = 0.008] increase for SC and OM, respectively). There was a much larger increase in PPARgamma2 expression, which was significantly greater in SC compared with OM preadipocytes (11.1 +/- 2.8-fold [P = 0.0003] and 5.5 +/- 1.7-fold [P = 0.0003], respectively; P = 0.014 for SC versus OM). To establish whether the refractoriness of OM preadipocytes to differentiation was unique to activators of the PPARgamma pathway, we examined the effects of the retinoid X receptor (RXR) ligand LG100268. As assessed by glycerol-3-phosphate dehydrogenase activity, LG100268 had a greater effect on the differentiation of SC compared with OM preadipocytes when examined alone (SC = 5.7 +/- 1.7-fold vs. OM = 1.9 +/- 0.6-fold; P < 0.05) or in combination with rosiglitazone (SC = 27.0 +/- 7.5 vs. OM = 10.6 +/- 3.6-fold; P < 0.05). Consistent with this, RXRalpha mRNA levels were also higher in SC than in OM preadipocytes. In summary, the previously reported insensitivity of OM preadipocytes to the differentiating effects of thiazolidinediones may relate to their lower basal levels of PPARgamma1 and gamma2 mRNA and their diminished capacity to upregulate PPARgamma2 expression in response to ligand. That omentally derived cells also show reduced responsiveness to the prodifferentiating actions of an RXR ligand and a lower expression of RXRa in the undifferentiated state suggests that they may have a more generalized resistance to differentiation.
引用
收藏
页码:718 / 723
页数:6
相关论文
共 35 条
  • [1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation
    Adams, M
    Montague, CT
    Prins, JB
    Holder, JC
    Smith, SA
    Sanders, L
    Digby, JE
    Sewter, CP
    Lazar, MA
    Chatterjee, VKK
    O'Rahilly, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 3149 - 3153
  • [2] PPAR-RXR HETERODIMER ACTIVATES A PEROXISOME PROLIFERATOR RESPONSE ELEMENT UPSTREAM OF THE BIFUNCTIONAL ENZYME GENE
    BARDOT, O
    ALDRIDGE, TC
    LATRUFFE, N
    GREEN, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) : 37 - 45
  • [3] Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice
    Berger, J
    Bailey, P
    Biswas, C
    Cullinan, CA
    Doebber, TW
    Hayes, NS
    Saperstein, R
    Smith, RG
    Leibowitz, MD
    [J]. ENDOCRINOLOGY, 1996, 137 (10) : 4189 - 4195
  • [4] DIFFERENCES AT THE RECEPTOR AND POSTRECEPTOR LEVELS BETWEEN HUMAN OMENTAL AND SUBCUTANEOUS ADIPOSE-TISSUE IN THE ACTION OF INSULIN ON LIPOLYSIS
    BOLINDER, J
    KAGER, L
    OSTMAN, J
    ARNER, P
    [J]. DIABETES, 1983, 32 (02) : 117 - 123
  • [5] RELATIONSHIP BETWEEN SKELETAL-MUSCLE INSULIN RESISTANCE, INSULIN-MEDIATED GLUCOSE DISPOSAL, AND INSULIN BINDING - EFFECTS OF OBESITY AND BODY-FAT TOPOGRAPHY
    EVANS, DJ
    MURRAY, R
    KISSEBAH, AH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) : 1515 - 1525
  • [6] THE ASSOCIATION OF BODY-FAT DISTRIBUTION WITH HYPERTENSION, HYPERTENSIVE HEART-DISEASE, CORONARY HEART-DISEASE, DIABETES AND CARDIOVASCULAR RISK-FACTORS IN MEN AND WOMEN AGED 18-79 YEARS
    GILLUM, RF
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 421 - 428
  • [7] REGIONAL OBESITY AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY
    KANNEL, WB
    CUPPLES, LA
    RAMASWAMI, R
    STOKES, J
    KREGER, BE
    HIGGINS, M
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (02) : 183 - 190
  • [8] Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
    Kelly, IE
    Han, TS
    Walsh, K
    Lean, MEJ
    [J]. DIABETES CARE, 1999, 22 (02) : 288 - 293
  • [9] RELATION OF BODY-FAT DISTRIBUTION TO METABOLIC COMPLICATIONS OF OBESITY
    KISSEBAH, AH
    VYDELINGUM, N
    MURRAY, R
    EVANS, DJ
    HARTZ, AJ
    KALKHOFF, RK
    ADAMS, PW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (02) : 254 - 260
  • [10] IMPACT OF OBESITY ON METABOLISM IN MEN AND WOMEN - IMPORTANCE OF REGIONAL ADIPOSE-TISSUE DISTRIBUTION
    KROTKIEWSKI, M
    BJORNTORP, P
    SJOSTROM, L
    SMITH, U
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) : 1150 - 1162